Viewing Study NCT05876806


Ignite Creation Date: 2025-12-26 @ 11:00 AM
Ignite Modification Date: 2025-12-26 @ 11:00 AM
Study NCT ID: NCT05876806
Status: RECRUITING
Last Update Posted: 2023-11-30
First Post: 2023-05-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Dabrafenib Plus Trametinib in Patients With Advanced Solid Tumor Having BRAF V600E Mutation or Clinically Actionable BRAF Gene Alterations
Sponsor: Se Jun Park
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module